BrainSpec Core™
Quantitative brain metabolite mapping for neurological disorders
Pre-clinicalActive
Key Facts
Indication
Quantitative brain metabolite mapping for neurological disorders
Phase
Pre-clinical
Status
Active
Company
About BrainSpec
BrainSpec is pioneering the clinical application of Magnetic Resonance Spectroscopy (MRS) through its cloud-based software platform, which transforms complex spectral data into actionable diagnostic insights. The company's mission is to make MRS as routine and interpretable as a blood test by creating reference databases for normal and diseased brain chemistry. Currently pending FDA clearance, BrainSpec is targeting both clinical diagnostics and research markets, with technology that leverages existing MRI infrastructure. Its academic roots at leading Boston hospitals provide a strong foundation in neuroscience and clinical radiology.
View full company profile